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Summary
 
The expression and secretion of interleukin (IL)-8, the prototype member of the C-X-C sub-
family of chemokines, can be induced by diverse inflammatory stimuli in many cells, including
endothelial cells (EC). Upon de novo synthesis, IL-8 localizes intracellularly in the Golgi appa-
ratus, from where it is secreted. In addition to this constitutive secretory pathway, we describe
a depot storage and separate regulated secretory pathway of IL-8 in EC.
The prolonged stimulation of primary human EC with inflammatory mediators resulted in
the accumulation of IL-8 in Weibel-Palade bodies, where it colocalized with von Willebrand
factor. IL-8 was retained in these storage organelles for several days after the removal of the
stimulus and could be released by EC secretagogues such as phorbol myristate acetate, the cal-
cium ionophore A23187, and histamine. These findings suggest that storage of IL-8 in Weibel-
Palade bodies may serve as the EC “memory” of a preceding inflammatory insult, which then
enables the cells to secrete IL-8 immediately without de novo protein synthesis.
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T
 
he egress of circulating leukocytes into the tissues con-
stitutes a prominent feature of inflammatory diseases.
Optimal leukocyte emigration requires the production of
leukocyte chemoattractants at the inflammatory sites and
the upregulation of different classes of adhesion molecules
on the surface of vascular endothelial cells (EC; reference
1). On the one hand, chemoattractants, including members
of the chemokine family (for a review, see reference 2), can
stimulate the activation of leukocyte integrins (for a review,
see reference 3). On the other hand, chemoattractants are
postulated to deliver directional cues during the transen-
dothelial migration of leukocytes (1). A prerequisite for the
in vivo activity of chemoattractants is that, after production
by different cells in the tissues, they diffuse to the vessel
wall and are then transported by the EC to the luminal sur-
face (4). Additionally, EC themselves can produce diverse
chemoattractants, including platelet-activating factor (PAF),
leukotriene B4, S100 chemotactic protein, and several
chemokines, such as IL-8, monocyte chemotactic proteins
1 and 3 (MCP-1 and MCP-3), RANTES (regulated upon
activation, normal T cell expressed and secreted), and eo-
taxin (2, 5–7).
The inflammatory EC activation follows two distinct
patterns, described as “delayed” (type II) and “immediate”
(type I; reference 8). In the delayed (type II) pattern, there
is a time delay of several hours between stimulation (e.g.,
with cytokines) and the EC expression of chemokines,
E-selectin, intercellular adhesion molecule (ICAM)-1, and
vascular cell adhesion molecule (VCAM)-1, which is due
to the requirement of de novo transcription and translation
(3). In contrast, in the immediate (type I) pattern, the ab-
sence of a time delay between stimulation and expression is
attributed to the preformation of adhesion molecules and
chemoattractants, which are exocytosed immediately after
stimulation from their cytoplasmic storage compartments.
In the case of lipid mediators such as PAF, the quick re-
sponse is explained by rapid synthesis. P-selectin and PAF
are a prototype adhesion molecule–chemoattractant pair
that appears on the EC surface subsequent to stimulation by
secretion from Weibel-Palade bodies and rapid synthesis,
respectively (9–11).
Weibel-Palade bodies are Golgi-derived, rod-shaped
storage organelles specific for EC (12). In addition to P-selec-
tin, the proteins stored in Weibel-Palade bodies include
von Willebrand factor (vWf [13]), endothelin (14), and
CD63 (15). Several stimuli, including PMA, calcium iono-
phore (A23187), thrombin, histamine, and fibrin, induce
the fusion of Weibel-Palade bodies with the plasma mem-
brane and the release of the stored contents (16). In this
study, we show that, after prolonged inflammatory stimula-
tion, IL-8 accumulates in Weibel-Palade bodies in primary
human EC, where it remains stored after the stimulation is
discontinued and can be released instantaneously upon re-
stimulation with EC secretagogues.
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Materials and Methods
 
Human umbilical vein EC (HUVEC) were prepared and grown
as described (17) and used at passages 3–5. The cells were positive
for vWf (
 
.
 
95% of the population). They were seeded into gelatin-
coated 96-well plates (Nunc, Inc., Naperville, IL) or 8-well LabTek
slides (Nunc, Inc.). After overnight adherence, the cells were stimu-
lated with 1,000 U/ml IL-1
 
b 
 
(Genzyme Corp., Cambridge, MA).
Secreted IL-8 was determined from the culture supernatants by
a conventional sandwich ELISA, and quantitative and qualitative
determinations of intracellular IL-8 were performed using a
mouse anti–IL-8 mAb (Novartis Forschungsinstitut [NFI] clone
4G9/A5) and the ELF
 
Ô
 
 detection system (Molecular Probes,
Inc., Eugene, OR), as described elsewhere (17). In the microtiter
plate experiments, the values were normalized to cell number,
determined by staining of cellular protein with sulforhodamine B
(Sigma Chemical Co., St. Louis, MO) as described (17) and cal-
culating cell number on the basis of a calibration curve.
For the double immunofluorescence studies, a rabbit poly-
clonal anti–IL-8 antibody (NFI) was used in combination with a
mouse mAb against a 58-kD Golgi protein (18; Sigma Chemical
Co.) and mouse anti–IL-8 mAbs from different sources (NFI
clone 4G9/A5; R&D Systems, Inc., Minneapolis, MN, and Im-
munoKontact, Frankfurt, Germany) in combination with a rabbit
polyclonal antibody against vWf (Dakopatts A/S, Glostrup, Den-
mark). The primary antibodies were detected with Texas red–
labeled goat anti–rabbit IgG (Accurate Chemical and Science
Corp., Westbury, NY) and OREGON GREEN
 
Ô
 
 500–labeled
goat anti–mouse IgG (Molecular Probes, Inc.). Nuclei were
counterstained with 4,6-diamidino-2-phenylindole (DAPI; Sigma
Chemical Co.). The slides were examined with a fluorescence
microscope (model IX 70; Olympus, Vienna, Austria) or with a
confocal laser scanning microscope (MRC 600; Bio-Rad Labora-
tories Ltd., Hemel Hempstead, UK) in the dual channel mode.
Images were merged using Bio-Rad software.
For immunoelectron microscopy, HUVEC were fixed (2%
paraformaldehyde, 0.05% glutaraldehyde), cryoprotected in 0.2 M
PBS containing 20% polyvinylpyrrolidone and 1.84 M sucrose
overnight at 4
 
8
 
C, and processed as described (19). Labeling was
performed with anti–IL-8 (NFI) and antioccludin (Zymed Labora-
tories, Inc., South San Francisco, CA) rabbit polyclonal antibodies,
and anti-vWf (Dakopatts A/S) and anti–L-selectin (Dreg 200; gift
of T.K. Kishimoto, Boehringer Ingelheim Pharmaceuticals, Ridge-
field, CT) mouse mAbs. Second antibodies were goat anti–rabbit
6-nm gold and goat anti–mouse 18-nm gold conjugates (Jackson
Immunoresearch Laboratories, Inc., Avondale, PA).
For the study of IL-8 release from Weibel-Palade bodies, cells
were stimulated with 1,000 U/ml IL-1
 
b 
 
in incubation medium
Figure 1. Immunolocalization of IL-8 in
HUVEC: Golgi apparatus and Weibel-
Palade bodies. HUVEC were stimulated
with 1,000 U/ml IL-1b for 4 h (a–c) or
overnight (d–l). Cells were fixed and per-
meabilized (a–i) or fixed only (j–l), and
colocalization experiments were performed
as described in Materials and Methods. Im-
ages (a–f ) were recorded with the confocal
laser scanning microscope (scale bar, 10 mm).
Localization of IL-8 (a) and the 58-kD
Golgi protein (b) is shown in two separate
cells and of IL-8 (d) and vWf (e) in one indi-
vidual cell. Images a and b were merged to
yield c, and the merged image of d and e is
shown in f; yellow, areas of colocalization.
Pictures g–l were photographed from an
Olympus IX 70 fluorescence microscope
(scale bar, 20 mm): IL-8 (g and j), vWf (h
and k), and DAPI (i and l). 
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(RPMI 1640 plus 10% FCS) overnight. They were washed three
times with PBS and incubated with incubation medium alone for
4 h. The medium was then replaced by fresh incubation medium
with or without secretagogues (10 nM PMA, 10 
 
m
 
M A23187, or
5 mM histamine; all from Sigma Chemical Co.) for 1 h. The su-
pernatants were removed, and intracellular and secreted IL-8
were determined.
 
Results and Discussion
 
Intracellular Localization of IL-8 in HUVEC after Stimula-
tion with IL-1
 
b
 
.
 
Previously, we determined the levels of
secreted and intracellular IL-8 in primary HUVEC compared
with EC lines and found them to produce 
 
z
 
8–10-fold higher
amounts of IL-8 (17). Therefore, HUVEC were chosen for
cellular localization studies. The optimal stimulus for HU-
VEC turned out to be IL-1
 
b
 
, followed by IL-1
 
a
 
, TNF-
 
a
 
,
and LPS. HUVEC stimulated with IL-1
 
b 
 
were used in all
experiments described below. As expected for a secreted
protein and described previously (17, 20), IL-8 (Fig. 1 
 
a
 
)
was found in the Golgi apparatus, where it colocalized with
a 58-kD protein that serves as a marker for this organelle
(18; Fig. 1 
 
b
 
). Colocalization of the two proteins, red and
green in individual images, is shown in yellow in the
merged confocal laser scanning image (Fig. 1 
 
c
 
). When
HUVEC were exposed to the stimulus for 8 h or more,
IL-8 immunoreactivity was also detected in Weibel-Palade
bodies, colocalizing with vWf (Fig. 1, 
 
d
 
–
 
h
 
). This was dem-
onstrated using two different antibody combinations, a
mouse anti–IL-8 mAb (Fig. 1, 
 
d
 
 and 
 
g
 
) and a rabbit poly-
clonal antibody against vWf (Fig. 1, 
 
e
 
 and 
 
h
 
), as well as a
rabbit polyclonal antibody directed against IL-8 in combi-
nation with a mouse mAb against vWf (immunofluores-
cence results not shown, but see Fig. 2). Colocalization of
IL-8 (Fig. 1 
 
d
 
) and vWf (Fig. 1 
 
e
 
) is demonstrated by the
yellow color in the merged confocal laser scanning image
(Fig. 1 
 
f
 
). Three different anti–IL-8 mAbs gave identical
results (not shown). Preincubation of the mouse anti–IL-8
mAb with a 2–5-fold molar excess of recombinant human
IL-8 (NFI) completely eliminated staining of both Golgi
apparatus and Weibel-Palade bodies, indicating the speci-
ficity of the staining reactions (results not shown). To con-
firm that the rod-shaped staining for IL-8 was indeed intra-
cellular and not cell surface–bound, permeabilized cells
(Fig. 1, 
 
g
 
–
 
i
 
) were compared with nonpermeabilized cells
(Fig. 1, 
 
j
 
–
 
l
 
) by conventional fluorescence microscopy.
Nonpermeabilized cells did not show any specific staining
for IL-8 (Fig. 1 
 
j
 
) or intracellular vWf (Fig. 1 
 
k
 
). The posi-
tion of the cells in Fig. 1, 
 
g
 
, 
 
h
 
, 
 
j
 
, and 
 
k
 
, is indicated by the
DAPI stain of the respective nuclei (Fig. 1, 
 
i
 
 and 
 
l
 
). IL-8 lo-
calization in Weibel-Palade bodies was also found in IL-1–
stimulated primary human microvascular EC (not shown).
The colocalization of IL-8 with vWf in Weibel-Palade
bodies was confirmed using immunoelectron microscopy
(Fig. 2). Nonspecific mouse monoclonal and rabbit poly-
clonal antibodies did not give any staining (Fig. 2, 
 
top left
inset
 
), and unstimulated HUVEC did not express IL-8 in
Weibel-Palade bodies (Fig. 2, 
 
bottom right inset
 
). After stim-
ulation with IL-1
 
b 
 
overnight, IL-8 was found both in the
Golgi apparatus (
 
short arrows
 
) and in Weibel-Palade bodies
(
 
long arrows
 
).
There was considerable heterogeneity between individ-
ual HUVEC preparations, with the number of cells con-
taining IL-8–positive Weibel-Palade bodies ranging from
10 to 90%. After overnight stimulation of HUVEC with
IL-1
 
b
 
 as well as with IL-1
 
a
 
, TNF-
 
a
 
, and LPS (results not
shown), three different types of IL-8 staining could be de-
tected: Golgi and Weibel-Palade bodies, Golgi only, and
Weibel-Palade bodies only. The percentages of these three
types varied between individual HUVEC preparations. In-
terestingly, not all Weibel-Palade bodies that contained
vWf also expressed IL-8. Curiously, in the human mi-
crovascular endothelial cell line HMEC-1, which does ex-
press vWf, no IL-8 immunoreactivity associated with Wei-
bel-Palade bodies could be detected. These observations
may reflect the detection limit for IL-8, since HMEC-1
cells expressed 
 
z
 
8–10-fold lower levels of IL-8 (17). The
minimal concentration of IL-1
 
b 
 
required for IL-8 storage
in Weibel-Palade bodies varied between individual HUVEC
preparations, ranging from 30 to 100 U/ml. Maximal in-
duction of other IL-1–inducible proteins was at 100 U/ml
(E-selectin) and 300 U/ml (VCAM-1 and ICAM-1).
Figure 2. Immunoelectron microscopic colocalization of IL-8 and vWf
in Weibel-Palade bodies. HUVEC were stimulated with 1,000 U/ml IL-1b
overnight and processed for electron microscopy as indicated in Materials
and Methods. Large granules (18-nm gold) represent vWf; small granules
(6-nm gold) correspond to IL-8. Short arrows, IL-8 in the Golgi apparatus;
long arrows, Weibel-Palade bodies that contain both IL-8 and vWf. Top left
inset, The absence of granules from Weibel-Palade bodies stained with the
irrelevant antibodies rabbit antioccludin and mouse anti–E-selectin. Bot-
tom right inset, Weibel-Palade bodies in unstimulated HUVEC contained
only vWf, but no IL-8. Scale bar, 100 nm. 
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Removal of IL-1
 
b 
 
Stimulus Led to a Release of IL-8 from the
Golgi Apparatus, but not from Weibel-Palade Bodies.
 
After
overnight stimulation of HUVEC with IL-1
 
b
 
, IL-8 was lo-
cated both in the Golgi apparatus and Weibel-Palade bod-
ies (Fig. 3 
 
a
 
). Upon removal of IL-1, intracellular levels of
IL-8 dropped rapidly over a period of 4–8 h, while the lev-
els of secreted IL-8 increased (Fig. 3 
 
c
 
). This secretion oc-
curred only from Golgi, whereas IL-8 associated with Wei-
bel-Palade bodies remained in the cells (Fig. 3 
 
b
 
) and could
still be detected in them 96 h after the removal of IL-1.
 
Addition of Secretagogues that Release vWf Induced Secretion
of IL-8 from Weibel-Palade Bodies.
 
A variety of EC secreta-
gogues, such as PMA, the ionophore A23187, thrombin,
histamine, and fibrin, have been shown to induce the release
of Weibel-Palade bodies’ contents (16). To investigate the
release of IL-8 from Weibel-Palade bodies, HUVEC were
stimulated with IL-1
 
b 
 
overnight and then incubated in fresh,
IL-1–free medium for 4 h. By this time, a negligible amount
of cell-associated IL-8 immunoreactivity was in the Golgi
apparatus, whereas the overwhelming majority of it was
 
present in Weibel-Palade bodies (Fig. 3 
 
b
 
). This pattern did
not change upon further incubation of HUVEC in medium
for 1 h (Fig. 4 
 
a). After the addition of PMA for 1 h, most of
the Weibel-Palade bodies lost their IL-8 immunoreactivity
(Fig. 4 b), while, consistent with the anticipated secretion,
the amount of IL-8 in the supernatant increased by 33.3 ng/
106 cells (from 31.4 to 64.7 ng/106 cells; Fig. 4 c). Similar re-
sults were obtained with A23187 and histamine (Fig. 4 c). As
expected, under the conditions used for IL-8 secretion, the
secretagogues also induced the release of vWf from Weibel-
Palade bodies (results not shown).
Western blot analysis of cell extracts with and without
removal of the IL-1 stimulus demonstrated that the IL-8
immunoreactivity seen in Weibel-Palade bodies in HUVEC
was identical to the 8.3-kD form of IL-8 (results not
shown).
EC and platelets share many molecular and cellular fea-
tures. Thus, P-selectin and vWf are not only constituents
of Weibel-Palade bodies in EC, but also of a-granules in
platelets (21). Interestingly, several members of the chemokine
Figure 3. Removal of IL-1b from stimulated HUVEC: effect on intracellular and secreted IL-8. HUVEC were stimulated with 1,000 U/ml IL-1b
overnight and then further incubated in IL-1–containing medium (a) or IL-1–free medium (b and c) for 4 h (b) or the times indicated (c). Secreted (open
circles) and intracellular (filled circles) IL-8 were determined as described in Materials and Methods, and are expressed as nanograms of IL-8 per 106 cells and
as arbitrary fluorescence units (FU) 3 1026 per 106 cells, respectively. Results are means 6 SD of triplicate samples.
Figure 4. Release of IL-8 from Weibel-Palade bodies by secretagogues: intracellular and secreted IL-8. HUVEC were stimulated with 1,000 U/ml
IL-1b overnight and then released into IL-1–free medium for 4 h. Control cells (a) and cells that were induced to release IL-8 from Weibel-Palade bodies
by the addition of 10 nM PMA (b and c), 10 mM A23187 (c), and 5 mM histamine (c) were examined after an additional 1 h. IL-8 was determined as de-
scribed in Materials and Methods; values are means 6 SD of triplicate samples.1761 Wolff et al. Brief Definitive Report
family, such as platelet factor 4 (22) and RANTES (23),
have been found stored in platelets. Recently, biologically
active IL-8 has also been identified in rabbit and human
platelets, and a substantial amount can be released upon
platelet activation (24). Platelets are functionally specialized
for hemostasis but may also have profound effects upon in-
flammatory reactions. Platelet aggregation may cause the
neutrophil infiltration observed at the initial phase of acute
inflammation through the release of preformed, stored
chemokines (24). The release of stored IL-8 from Weibel-
Palade bodies in the EC that have previously experienced
inflammatory stimulation may have a similar function: it is
rapid and independent of de novo protein synthesis. Thus,
IL-8 together with P-selectin, which is constitutively present
in Weibel-Palade bodies (9, 10), may be part of the im-
mediate EC response (type I endothelial activation). Pre-
viously, the role of IL-8 has been limited to the type II EC
activation responses where it may act in synchrony with
E-selectin (25).
The EC of the blood vessels in organs and tissues that
border the external environment may represent a special
case. Due to their anatomical location, these EC may expe-
rience chronic inflammatory stimulation and, as a result,
constitutively express significant amounts of IL-8 in Wei-
bel-Palade bodies (26). Therefore, EC in some locations
may be able to release IL-8 immediately upon stimulation
with EC secretagogues.
In conclusion, we describe the storage of IL-8 in Wei-
bel-Palade bodies, which may serve as a substrate of a rudi-
mentary EC memory of a previously suffered inflammatory
insult. Such memory may play a previously unrecognized
role in disease settings where chronic EC stimulation leads
to accumulation of IL-8 in Weibel-Palade bodies and its
rapid “recall” is induced by a second stimulus at a later time
point. For example, protracted periods of hypoxia in the
organs before their transplantation or during cardiopulmo-
nary bypass surgery may induce the production of IL-8 by
the EC (27) and its accumulation in Weibel-Palade bodies.
After transplantation or during reperfusion at the end of
cardiopulmonary bypass, thrombin, histamine (28), or other
stimuli which lead to type I EC activation may result in
immediate massive release of the stored IL-8. Rapid IL-8
release from an unknown source has been described to take
place after pediatric cardiopulmonary bypass surgery, and
has been suggested to contribute to leukocyte activation
and postoperative pulmonary complications (29). It will be
of interest to determine if IL-8 stored in Weibel-Palade
bodies plays a pathophysiological role in this case and in
other clinically relevant disease situations.
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